ADH-1 trifluoroacetate
ADH-1 trifluoroacetate (Exherin) is a cyclic pentapeptide that selectively inhibits N-cadherin, disrupting tumor vasculature and inducing apoptosis. It is used in cancer research for its antiangiogenic properties, studied in both in vitro models and in vivo xenograft experiments targeting N-cadherin-expressing tumors.
Product Specifications
Product Name Alternative
ADH 1, ADH 1 Trifluoroacetate, ADH 1 trifluoroacetate, ADH1, ADH-1, ADH1 trifluoroacetate, ADH1 Trifluoroacetate, ADH-1 Trifluoroacetate, Exherin trifluoroacetate, Exherin Trifluoroacetate, Inhibitor, N-cadherin, inhibit
Field of Research
Metabolism Research, Signal Transduction
Purity
90.08% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (2.92 mM) ; DMSO:43 mg/mL (62.8 mM)
Molecular Weight
684.71
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1226740 Inquire
Recombinant Stenotrophomonas maltophilia Translation initiation factor IF-2 (infB), partial
Sign In for Pricing
View Details 
T2040-05T-FITC 100 Tests
TCR, gamma, delta (T Cell Receptor) (FITC)
Sign In for Pricing
View Details